Journal of International Oncology››2022,Vol. 49››Issue (8): 505-508.doi:10.3760/cma.j.cn371439-20220121-00097
Previous ArticlesNext Articles
Received:2022-01-21Revised:2022-03-15Online:2022-08-08Published:2022-09-21
"
"
"
| [1] | 杨晨光, 徐志巧. 驱动基因阳性晚期非小细胞肺癌靶向治疗[J]. 国际肿瘤学杂志, 2021, 48(4): 235-240. DOI: 10.3760/cma.j.cn371439-20200911-00047. doi:10.3760/cma.j.cn371439-20200911-00047 |
| [2] | Subbiah V, Yang D, Velcheti V, et al. State-of-the-art strategies for targeting RET-dependent cancers[J]. J Clin Oncol, 2020, 38(11): 1209-1221. DOI: 10.1200/JCO.19.02551. doi:10.1200/JCO.19.02551pmid:32083997 |
| [3] | Li AY, McCusker MG, Russo A, et al. RET fusions in solid tumors[J]. Cancer Treat Rev, 2019, 81: 101911. DOI: 10.1016/j.ctrv.2019.101911. doi:10.1016/j.ctrv.2019.101911 |
| [4] | Tan AC, Seet AOL, Lai GGY, et al. Molecular characterization and clinical outcomes in RET-rearranged NSCLC[J]. J Thorac Oncol, 2020, 15(12): 1928-1934. DOI: 10.1016/j.jtho.2020.08.011. doi:10.1016/j.jtho.2020.08.011 |
| [5] | 郑玉军, 姜巍, 陈东妍, 等. RET融合型非小细胞肺癌的研究进展[J]. 中国肺癌杂志, 2021, 24(8): 591-597. DOI: 10.3779/j.issn.1009-3419.2021.102.22. doi:10.3779/j.issn.1009-3419.2021.102.22 |
| [6] | Gainor JF, Curigliano G, Kim DW, et al. Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study[J]. Lancet Oncol, 2021, 22(7): 959-969. DOI: 10.1016/S1470-2045(21)00247-3. doi:10.1016/S1470-2045(21)00247-3 |
| [7] | Piotrowska Z, Isozaki H, Lennerz JK, et al. Landscape of acquired resistance to osimertinib in EGFR-mutant NSCLC and clinical validation of combined EGFR and RET inhibition with osimertinib and BLU-667 for acquired RET fusion[J]. Cancer Discov, 2018, 8(12): 1529-1539. DOI: 10.1158/2159-8290.CD-18-1022. doi:10.1158/2159-8290.CD-18-1022pmid:30257958 |
| [8] | Parker NA, McBride C, Forge J, et al. Bowel obstruction caused by colonic metastasis of lung adenocarcinoma: a case report and literature review[J]. World J Surg Oncol, 2019, 17(1): 63. DOI: 10.1186/s12957-019-1611-y. doi:10.1186/s12957-019-1611-ypmid:30961608 |
| [9] | Antler AS, Ough Y, Pitchumoni CS, et al. Gastrointestinal metastases from malignant tumors of the lung[J]. Cancer, 1982, 49(1): 170-172.DOI： 10.1002/1097-0142（19820101）49：1<170：：aid-cncr2820490134>3.0.co；2-a. pmid:6274500 |
| [10] | Stenbygaard LE, Sørensen JB. Small bowel metastases in non-small cell lung cancer[J]. Lung Cancer, 1999, 26(2): 95-101. DOI: 10.1016/s0169-5002(99)00075-6. doi:10.1016/s0169-5002(99)00075-6pmid:10568680 |
| [11] | McNeill PM, Wagman LD, Neifeld JP. Small bowel metastases from primary carcinoma of the lung[J]. Cancer, 1987, 59(8): 1486-1489.DOI： 10.1002/1097-0142（19870415）59：8<1486：：aid-cncr2820590815>3.0.co；2-w. pmid:3028602 |
| [12] | Rossi G, Marchioni A, Romagnani E, et al. Primary lung cancer presenting with gastrointestinal tract involvement: clinicopathologic and immunohistochemical features in a series of 18 consecutive cases[J]. J Thorac Oncol, 2007, 2(2): 115-120. DOI: 10.1016/S1556-0864(15)30037-X. doi:10.1016/S1556-0864(15)30037-X |
| [13] | Gitt SM, Flint P, Fredell CH, et al. Bowel perforation due to metastatic lung cancer[J]. J Surg Oncol, 1992, 51(4): 287-291. DOI: 10.1002/jso.2930510417. doi:10.1002/jso.2930510417pmid:1434663 |
| [14] | Salemis NS, Nikou E, Liatsos C, et al. Small bowel perforation secondary to metastatic non-small cell lung cancer. A rare entity with a dismal prognosis[J]. J Gastrointest Cancer, 2012, 43(3): 391-395. DOI: 10.1007/s12029-011-9329-2. doi:10.1007/s12029-011-9329-2 |
| [15] | Taira N, Kawabata T, Gabe A, et al. Analysis of gastrointestinal metastasis of primary lung cancer: clinical characteristics and prognosis[J]. Oncol Lett, 2017, 14(2): 2399-2404. DOI: 10.3892/ol.2017.6382. doi:10.3892/ol.2017.6382 |
| [16] | Hu Y, Feit N, Huang Y, et al. Gastrointestinal metastasis of primary lung cancer: an analysis of 366 cases[J]. Oncol Lett, 2018, 15(6): 9766-9776. DOI: 10.3892/ol.2018.8575. doi:10.3892/ol.2018.8575 |
| [17] | Di JZ, Peng JY, Wang ZG. Prevalence, clinicopathological cha-racteristics, treatment, and prognosis of intestinal metastasis of primary lung cancer: a comprehensive review[J]. Surg Oncol, 2014, 23(2): 72-80. DOI: 10.1016/j.suronc.2014.02.004. doi:10.1016/j.suronc.2014.02.004 |
| [18] | Moreno-Aguilera E, Galeana-Nogueda FI, Vera-Aguilera J, et al. Jejunal perforation secondary to pulmonary mucoepidermoid carcinoma metastasis. Case report and review[J]. Cir Cir, 2017, 85(3): 254-259. DOI: 10.1016/j.circir.2016.03.006. doi:S0009-7411(16)30018-4pmid:27260218 |
| No related articles found! |
| Viewed | ||||||
| Full text |
|
|||||
| Abstract |
|
|||||
